Investors   |    About Cambrex   |    Contact Us   |    Careers   |    Login
Search Site
Advanced Search
Site Map
Lonza Sale
Cambrex has completed the sale of the Research Products and Microbial Biopharmaceutical business to Lonza. Please use the links below for redirection to their site.
 
Research Products
Custom Media
Flexible Packaging
Endotoxin Detection
Cell Therapy
Testing Services
Shareholder Information
IntraDay Stock Quote
Last UpdatePriceChangeVolume
Jul 3, 2008 1:09 p.m. ET$5.45 Stock is Down 0.14102,752
Historic Stock Graphs

Cambrex provides products and services to accelerate the development and commercialization of branded and generic small molecule therapeutics.


Stock Exchange  New York Stock Exchange (NYSE)
Stock Symbol  CBM
Contact
Greg Sargen
Vice President and Chief Financial Officer
Phone: 201-804-3037
Fax: 201-804-9852
Email: gregory.sargen@cambrex.com

Transfer Agent
American Stock Transfer & Trust Company
40 Wall Street
New York, NY 10005
Phone: 800-937-5449
Email: info@amstock.com

Independent Accountants
BDO Seidman

Annual Shareholder Meeting
April 24, 2008 at 1:00 PM
Sheraton Meadowlands Hotel & Conference Center Two Meadowlands Plaza
East Rutherford, NJ 07073
News Releases
05/15/08
Cambrex Appoints Steven M. Klosk as President and CEO
05/01/08
Cambrex Reports First Quarter 2008 Results
04/24/08
Cambrex to Announce First Quarter 2008 Financial Results on May 1, 2008
More >>
Investor Relations
Shareholder Information
Governance
Stock Information
Fundamentals
Annual Reports
News Releases
Email Alerts
Events
Webcasts & Presentations
SEC Documents
Analyst Lists
Printed Materials
Dividend History
Management
   
  ©Copyright 2007 Cambrex Corporation. Reproduction of any elements of this site for commercial use is prohibited. Please read our Privacy Policy and Disclaimers before proceeding though this site. Best viewed at a screen resolution of 1024 x 768 or higher.